Dr Hadi Chakor
Chief Medical Officer (CMO)
Since joining the company in 2017, Dr. Chakor has structured DIAGNOS’ clinical validation efforts to transform artificial intelligence into an instrument of medical precision. His background, enriched by doctoral research in microcirculation and preventive medicine, has enabled the company to take a decisive step forward—from basic image detection to the development of complex predictive models. Under his supervision, DIAGNOS has firmly anchored its solutions within the demanding medical device sector, ensuring that every algorithm complies with the strictest clinical safety protocols.
His expertise makes him a true clinical sentinel, capable of bridging fundamental research and the realities of frontline care. An active member of prestigious institutions such as ARVO (Association for Research in Vision and Ophthalmology) and the ICO (International Council of Ophthalmology), he has notably led the development of innovative technologies for the early detection of retinal and cardiovascular disease. His scientific leadership has been recognized through awards of excellence, including the Jean-Louis Lévesque Prize, highlighting his contribution to advancing preventive healthcare in Canada.
As the architect of DIAGNOS’ Clinical Alliance, he ensures that cutting-edge innovation directly serves healthcare professionals’ effectiveness. His vision is grounded in absolute precision: transforming raw data into verified, actionable information that helps protect patients’ health trajectories.
